7-81950516-TAAAAA-TAAAA
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP6_ModerateBS2
The NM_000722.4(CACNA2D1):c.3160-9del variant causes a splice polypyrimidine tract, intron change. The variant allele was found at a frequency of 0.00148 in 1,413,882 control chromosomes in the GnomAD database, including 3 homozygotes. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.00027 ( 0 hom., cov: 31)
Exomes 𝑓: 0.0016 ( 3 hom. )
Consequence
CACNA2D1
NM_000722.4 splice_polypyrimidine_tract, intron
NM_000722.4 splice_polypyrimidine_tract, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 4.16
Genes affected
CACNA2D1 (HGNC:1399): (calcium voltage-gated channel auxiliary subunit alpha2delta 1) The preproprotein encoded by this gene is cleaved into multiple chains that comprise the alpha-2 and delta subunits of the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. Mutations in this gene can cause cardiac deficiencies, including Brugada syndrome and short QT syndrome. Alternate splicing results in multiple transcript variants, some of which may lack the delta subunit portion. [provided by RefSeq, Nov 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP6
Variant 7-81950516-TA-T is Benign according to our data. Variant chr7-81950516-TA-T is described in ClinVar as [Benign]. Clinvar id is 1165755.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr7-81950516-TA-T is described in Lovd as [Benign]. Variant chr7-81950516-TA-T is described in Lovd as [Likely_benign]. Variant chr7-81950516-TA-T is described in Lovd as [Benign].
BS2
High AC in GnomAd4 at 40 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CACNA2D1 | NM_000722.4 | c.3160-9del | splice_polypyrimidine_tract_variant, intron_variant | ENST00000356860.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CACNA2D1 | ENST00000356860.8 | c.3160-9del | splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_000722.4 | ||||
CACNA2D1 | ENST00000443883.2 | c.3196-9del | splice_polypyrimidine_tract_variant, intron_variant | 5 | P1 | ||||
CACNA2D1 | ENST00000705961.1 | c.2927-9del | splice_polypyrimidine_tract_variant, intron_variant | ||||||
CACNA2D1 | ENST00000705962.1 | c.3040-9del | splice_polypyrimidine_tract_variant, intron_variant |
Frequencies
GnomAD3 genomes AF: 0.000278 AC: 41AN: 147472Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
41
AN:
147472
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00956 AC: 1531AN: 160184Hom.: 0 AF XY: 0.0100 AC XY: 864AN XY: 86236
GnomAD3 exomes
AF:
AC:
1531
AN:
160184
Hom.:
AF XY:
AC XY:
864
AN XY:
86236
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00162 AC: 2054AN: 1266320Hom.: 3 Cov.: 31 AF XY: 0.00182 AC XY: 1143AN XY: 629472
GnomAD4 exome
AF:
AC:
2054
AN:
1266320
Hom.:
Cov.:
31
AF XY:
AC XY:
1143
AN XY:
629472
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000271 AC: 40AN: 147562Hom.: 0 Cov.: 31 AF XY: 0.000320 AC XY: 23AN XY: 71816
GnomAD4 genome
AF:
AC:
40
AN:
147562
Hom.:
Cov.:
31
AF XY:
AC XY:
23
AN XY:
71816
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
not provided Benign:1
Likely benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
Brugada syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 15, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at